A patient with myasthenia gravis experiences muscle weakness. Which mechanism explains why acetylcholine esterase inhibitors improve muscle function in these patients?

💡 Explanation

Myasthenia gravis involves autoimmune destruction of acetylcholine receptors; therefore, acetylcholine esterase inhibitors increase the concentration of acetylcholine at the synapse by inhibiting its breakdown, because this compensates for the reduced number of functional receptors, rather than blocking receptors or affecting production.

• If chronic psychological stress elevates cortisol, why does bone density decline more sharply during aging, rather than exhibiting immediate and reversible changes?
• Which risk increases when sustained traumatic crush injuries trigger widespread tissue breakdown?
• If a patient has damaged osmoreceptors, leading to decreased sensitivity to plasma osmolality, which consequence is most likely regarding water balance regulation during dehydration?
• Why does blood pressure increase when blood vessels narrow?
• If a patient develops chronic hypoxemia due to advanced COPD, which compensatory mechanism involving 2,3-BPG (2,3-bisphosphoglycerate) helps to maintain adequate tissue oxygen delivery despite reduced arterial oxygen saturation?
• Why does chronic NSAID use increase gastrointestinal ulcer risk despite blocking prostaglandin synthesis?